Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Feb;134(2):135-6.
doi: 10.1001/jamaophthalmol.2015.4652.

Drilling Deeper for Treatment Choices in Diabetic Macular Edema

Affiliations
Comment

Drilling Deeper for Treatment Choices in Diabetic Macular Edema

Emily Y Chew. JAMA Ophthalmol. 2016 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.

Comment on

References

    1. Wells JA, Glassman AR, Jampol LM, et al.; Diabetic Retinopathy Clinical Research Network. Association of baseline visual acuity and retinal thickness with 1-year efficacy of aflibercept, bevacizumab, and ranibizumab for diabetic macular edema [published online November 25, 2015]. JAMA Ophthalmol. doi:10.1001/jamaophthalmol.2015.4599. - DOI - PMC - PubMed
    1. Wells JA, Glassman AR, Ayala AR, et al.; Diabetic Retinopathy Clinical Research Network. Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema. N Engl J Med. 2015;372(13):1193–1203. - PMC - PubMed
    1. Browning DJ, Glassman AR, Aiello LP, et al.; Diabetic Retinopathy Clinical Research Network. Relationship between optical coherence tomography–measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology. 2007;114(3):525–536. - PMC - PubMed
    1. Early Treatment Diabetic Retinopathy Study Research Group. Focal photocoagulation treatment of diabetic macular edema: relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS Report No. 19. Arch Ophthalmol. 1995;113(9):1144–1155. - PubMed

Substances